Item 9 Labs (OTC:INLB) Shares Down 5.7%
Item 9 Labs (OTC:INLB) Shares Down 5.7%
Item 9 Labs Corp. (OTC:INLB – Get Rating)'s share price fell 5.7% on Tuesday . The company traded as low as $0.25 and last traded at $0.25. 33,714 shares traded hands during trading, an increase of 73% from the average session volume of 19,515 shares. The stock had previously closed at $0.27.
Item 9 Labs Corp.(场外交易代码：INLB-GET Rating)的股价周二下跌5.7%。该公司股价一度跌至0.25美元，最新报0.25美元。33,714股股票在交易中成交，较19,515股的平均成交量增加了73%。该股此前收盘报0.27美元。
Item 9 Labs Stock Down 5.7 %
第9项实验室库存下降5.7%
The firm has a market cap of $24.42 million, a P/E ratio of -1.00 and a beta of 0.33. The business's fifty day moving average price is $0.30 and its two-hundred day moving average price is $0.53. The company has a current ratio of 0.14, a quick ratio of 0.04 and a debt-to-equity ratio of 0.02.
该公司市值为2442万美元，市盈率为-1.00，贝塔系数为0.33。该业务的50日移动均线价格为0.30美元，200日移动均线价格为0.53美元。该公司的流动比率为0.14，速动比率为0.04，债务权益比率为0.02。
Item 9 Labs Company Profile
第9项实验室公司简介
(Get Rating)
(获取评级)
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona.
第九项实验室公司在美国是一家垂直整合的大麻运营商和药房特许经营商。该公司生产各种类别的大麻和大麻相关产品，如鲜花、浓缩物、蒸馏液和五金制品。它通过获得许可的药房向亚利桑那州的消费者提供大麻和大麻衍生产品和技术。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Item 9 Labs (INLB)
- We Are the Champions: 3 Dividend Growers Wall Street Loves
- Will Nordstrom Stock be the Grinch This Year?
- Harpoon Therapeutics Remains Volatile After Promising News
- What is Market Structure in Trading?
- Institutional Selling Is No Headwind For Nike
- 免费获取StockNews.com关于第9项实验室的研究报告(INLB)
- 我们是冠军：华尔街钟爱的3位股息种植者
- 诺德斯特龙股票公司会成为今年的格林奇吗？
- 鱼叉治疗公司在有希望的消息传出后仍不稳定
- 交易中的市场结构是什么？
- 机构销售对耐克来说不是逆风
Receive News & Ratings for Item 9 Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Item 9 Labs and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收第九项实验的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收关于Item 9实验室和相关公司的最新新闻和分析师评级的每日简要摘要。
译文内容由第三方软件翻译。